Upcoming Events

ASEAN Dx Preparedness Webinar Series

ASEAN Dx is a platform endorsed by ASEAN Ministerial meeting in 2018 and co-chaired by the Philippines and Singapore. In this webinar series, we bring together experts in the field to raise awareness on COVID-19 preparedness strategies.

Past Events


Vaccines and Immunity: Is Omicron the last threat?

SARS-CoV-2 variations are keeping us on our toes in our fight against COVID-19. WHO announced in late November that there is a Variant of Concern (VOC), Omicron, with 32 mutations in the spike protein. This is about double that of the Delta strain, which is currently dominating COVID-19 infections around the world. This new VOC is expected to be more transmissible and infectious than the Delta strain. How quickly and widely would Omicron spread? Would it dominate the other variants? Would this new variant reduce vaccine effectiveness? In this webinar, we will discuss the recent developments in our fight against COVID-19 and changes in vaccination programmes to effectively combat Omicron.

Watch the webinar here:

Click to view the Vaccines and Immunity 2 Webinar Report

Vaccines and Immunity


<Webinar> Vaccines and Immunity: When can we achieve herd immunity?

Aggressive vaccination programmes are underway in ASEAN, even as new variants appear on the horizon. What do we know about these variants and the challenges they pose to sero-conversion in a vaccinated population, longevity of host immunity, and achieving the ‘holy grail’ of herd immunity? Earlier estimates for achieving herd immunity to SARS-CoV-2 were 60-70%. The new estimate is 80-90% due to the spread of SARS-CoV-2 Delta variant, according to a report from Infectious Diseases Society of America on Aug 3, 2021. In this webinar, we will discuss ongoing vaccination efforts using various vaccines, challenges posed by mutating virus and possible approaches to eventually achieve herd immunity to SARS-CoV-2.

Additionally, the webinar will introduce the ASEAN Serosurveillance Study for COVID-19 Vaccines. The study is coordinated by ASEAN Dx Initiative and supported by Temasek Foundation.

Watch the webinar here:

Click to view the Vaccines and Immunity Webinar Report


Genomic Surveillance


<Webinar> Genomic Surveillance for SARS-CoV-2 Variants: What is the impact and why we need it now?

SARS-CoV-2 has been continuously mutating. The delta variant is now the dominant variant globally, and the lambda variant has already spread to 29 countries. Details about the evolution of the virus are analysed by epidemiologists to advise about incidence, distribution, and control of diseases. Understanding the evolving genome sequences of SARS-CoV-2 informs participants two important things – how the virus is mutating and how it is moving through the population. In this webinar, we will introduce the use of Next Generation Sequencing (NGS) for virus variants surveillance. With public health interventions adjusted accordingly, we can control the rampant spread of new variants through the country and globally.

Watch the webinar here:

Click to view the Genomic Surveillance Webinar Report


Direct PCR


<Webinar> Direct PCR as an alternative platform to conventional PCR

Viral RNA detection through RT-PCR is WHO’s recommended confirmatory test for SARS-CoV-2 infection. However, many countries faced challenges in ramping up RT-PCR testing capacity, such as shortage of swab sticks, transport media, RNA extraction reagents and costly platform equipment. The testing demands have led to the development of alternative PCR protocols with similar sensitivities to relieve the testing load. In this webinar, we discuss how using direct PCR test can manage COVID-19 testing demands. 

Watch the webinar here: 

Click to view the Direct PCR Webinar Report

Click to view the ASEAN Dx Preparedness Webinar: Testing Platforms



<Webinar> COVID-19: Vaccines, Immunity, and Diagnostics

As excitement soars over pending COVID-19 vaccination programmes in 2021, it is timely to know how an effective vaccine works in producing virus neutralizing antibodies in recipients that generates immunity, and how serology monitoring can measure herd immunity.

In this webinar, Prof. Wang Linfa will explore the importance of serology testing in managing the next phase of COVID-19, how it may impact public health policies, and its role in enhancing our preparedness for future pandemics.

Dr. Sergio Carmona and Dr. Emma Hannay will discuss the efforts of FIND in guiding and providing access to tools supporting the fight against the pandemic. This is done through the Access to COVID-19 Tools (ACT) Accelerator, an initiative led by FIND, the Global Fund, WHO and other global partners.

Watch the webinar here: 

Free Course on Microbiology Laboratory Techniques to Address AMR in Africa, Asia and Latin America


With a tentative launch date of 27 April 2022

The Global Health Continuing Professional Development (GHCPD) program, in collaboration with the International Diagnostics Centre at the London School of Hygiene and Tropical Medicine (IDC/LSHTM) will be offering a free 3-week online course covering the role of the microbiology laboratory in the fight against antimicrobial resistance (AMR).

This unique course will use e-learning modalities, such as mini-lectures, animations, practical training videos and discussion forums, to address basic principles and applications of microbiology laboratory techniques for AMR. All courses are taught by internationally known expert faculty who will be available for the discussion forums and to answer questions.



Global Health Continuing Professional Development is a free, digital learning platform developed in response to increasing need for education opportunities in diagnostics in order to strengthen laboratory and testing programs and improve health services and patient care in LMICs.

For more information, please visit



The ASEAN Regional Consultation, held on 16 February 2022, was organised by ASEAN DxI and LSHTM as a proactive step to consolidate the learnings and recommendations from ASEAN countries for future pandemic preparedness. It sought to share key findings, experiences and best practices of member ASEAN countries and establish the follow-up measures needed in diagnostics capacity building based on the lessons learned over the last two years.


The discussions during the regional consultation generated some common considerations that focused around 4 areas:

           1) Regulatory,
           2) Product development & quality assurance,
           3) Diagnostics capacity building and
           4) Collaboration with public health and policy makers.

Participants are confident that these measures would provide the necessary impact towards improving access to diagnostics across the ASEAN region.

For the full report see <link to full report>